MedTrace Logo

Socioeconomic Aspects Before and After Radiation Therapy in Patient With Prostate Cancer

NCT01849471 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-08-01

No results posted yet for this study

Summary

This trial is an interrogation of patients with prostate cancer to evaluate socioeconomic effects of radiotherapy. Patients with percutaneous or interstitial or combined percutaneous and interstitial radiotherapy are included. Beside medical effects and adverse events, it's prospectively needed to extensively inform patients about socioeconomic aspects associated with radiotherapy. The interrogation comprises to collect possible costs and expenditures during and after therapy. Aspects especially concerning post therapy period include additional consultations, individual applied alternative medical care, need for additional medical aids (salves, medicine, bandages) and changes in professional and social situation. It's figured out in what extend costs are absorbed by health insurance coverage. In Germany there is no appropriate trial with respective patient population and respective therapy. Primary endpoint is the evaluation of therapy concerning and follow-up costs as well as changes in social and professional situation. Secondary endpoints are quality of life, adverse events of therapy and the correlation of quality of life, adverse events and economic aspects for the patient and the health insurance coverage.

Conditions

Interventions

OTHER

questionnaires

patients receive questionnaires regarding socioeconomic aspects before, during and after therapy

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Annedore Strnad, MD, MHBA · Strahlenklinik, Universitätsklinikum Erlangen

  • Rainer Fietkau, MD · Strahlenklinik, Universitätsklinikum Erlangen

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01849471 on ClinicalTrials.gov